Due to the requirement for comprehensive clinical research efforts in China, the importance of biobanking in modern clinical research is outlined in this overview. Hospitals, universities, and research institutes have been well organized as fundamental resources for Chinese biobanking initiatives and the resulting bio-sample collections. Here, a brief history and time line of development of biobanking in China will be introduced, as well as strategic designs for future biobanking development.
Get full access to this article
View all access options for this article.
References
1.
ChuJY, XuJJ, FuSB, et al.The establishment of the immortalize cell bank of different Chinese ethnic groups. Intl J Genetics, 2008; 31:241–247.
2.
SungWC. Risk and the development of biobanking in China. In: MargaretSF, ed. Human Genetic Biobanks in Asia: Politics of Trust and Scientific Advancement. Routledge Contemporary Asia Series; 2008; 168–180.
3.
CaoZF, CaoYR, MaLG, et al.Standardization for sharing and utilization of Chinese genetic resources. Hereditas (Beijing), 2008; 30:51–58.
WangXF, LuM, QianJ, et al.Rationales, design and recruitment of the Taizhou Longitudinal Study. BMC Public Health, 2009; 9:223.
13.
LiuM, HuQL. A proposed approach to informed consent for biobanks in China. Bioethics, 2014; 28:181–186.
14.
MaY, DaiHL, WangLM, et al.Consent for use of clinical leftover biosample: A survey among Chinese patients and the general public. PLoS One, 2012; 7:e36050.
